Trial Profile
Comparison between long acting insulin analogue and biphasic insulin aspart30/70 (BIAsp 30) as combination therapy with oral anti-diabetic agents.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin aspart (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- 10 Mar 2011 New trial record